Search Ontology:
ChEBI
nelociguat
- Term ID
- CHEBI:149785
- Synonyms
-
- BAY 60-4552
- BAY-60-4552
- BAY60-4552
- methyl (4,6-diamino-2-{1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl}pyrimidin-5-yl)carbamate
- methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}carbamate
- nelociguat
- nelociguatum
- Definition
- A member of the class of pyrazolopyridines that is 1H-pyrazolo[3,4-b]pyridine which is substituted by a 2-fluorobenzyl and 4,6-diamino-5-[(methoxycarbonyl)amino]pyrimidin-2-yl groups at positions 1 and 3, respectively. It is an active metabolite of riociguat and a soluble guanylate cyclase stimulator developed by Bayer for the treatment of erectile dysfunction and heart failure.
- References
-
- CAS:625115-52-8
- PMCID:PMC3313365
- PMCID:PMC3363255
- PMID:21839578
- PMID:22783192
- PMID:23421435
- PMID:24092345
- PMID:25587836
- PMID:27784018
- PMID:28360348
- Patent:WO2011073118
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has_role
-
Phenotype
Phenotype resulting from nelociguat
Phenotype where environments contain nelociguat
Phenotype modified by environments containing nelociguat
Human Disease Model